MARATTO

article · Journal of Pharmaceutical Policy and Practice

Transparency and corruption risk in pharmaceutical procurement practices at public health facilities in Northeast Ethiopia: a multi-facility study

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The pharmaceutical procurement practice at the health facilities was generally found to be very vulnerable to corruption, which slightly increased with a decrease in facility levels and vice versa.

Research topics

  • Pharmaceutical Economics and Policy
  • Pharmaceutical Quality and Counterfeiting
  • Public Procurement and Policy

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/20523211.2024.2432446

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.